By San José, Costa Rica — San José is preparing to host one of the region’s most prominent healthcare summits as Expomed 2026 convenes on November 24, 2026. The 17th edition of the National Health Forum will gather at the Hotel Crowne Plaza in La Sabana, serving as a critical platform for industry stakeholders navigating structural changes in Latin American medical systems.
Organized by the Costa Rican Chamber of Health (Cámara Costarricense de la Salud), the high-level forum is expected to draw roughly 500 key leaders. Participants will represent a diverse cross-section of the ecosystem, uniting public institution officials, private healthcare executives, academic researchers, and medical technology developers under one roof.
To better understand the regulatory, corporate, and investment implications surrounding an event like Expomed 2026, TicosLand.com spoke with legal expert Lic. Larry Hans Arroyo Vargas from the firm Bufete de Costa Rica, who provided valuable insights into the legal landscape shaping the healthcare and medical technology sectors.
Expomed 2026 represents a major strategic opportunity for Costa Rica’s healthcare and life sciences industries. However, international and domestic enterprises entering new commercial agreements or introducing innovations must proactively manage Ministry of Health sanitary registrations, intellectual property safeguards, and local distribution contracts to ensure seamless compliance and minimize legal risk.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Navigating Costa Rica’s regulatory and legal landscape is indeed the cornerstone for turning the vast potential of Expomed 2026 into lasting commercial success. We extend our sincere thanks to Lic. Larry Hans Arroyo Vargas for providing his valuable perspective on how businesses can protect their innovations and ensure full compliance in this rapidly evolving sector.
The central thematic focus of this year’s convention centers on maximizing the yield of health sector investments, building resilient frameworks to combat rising rates of chronic disease, and modernizing patient service delivery mechanisms across national networks.
Industry leaders emphasize that the value of such large-scale assemblies extends far beyond routine policy discussions, offering a venue where theoretical strategies can translate into actionable public-private frameworks.
Its value lies in the connections built and the possibility of turning that dialogue into projects that improve people’s care.
Massimo Manzi, Executive Director of the Costa Rican Chamber of Health
The comprehensive agenda scheduled for Expomed 2026 reflects the pressing issues facing regional healthcare systems today. Key modules will focus on financial sustainability for national health systems, cutting-edge biomedical research, digital health infrastructure adoption, and removing structural barriers to ensure equitable access to essential medicines.
A recurring priority for organizers is ensuring that technological advancements and capital investments remain directly aligned with practical clinical outcomes rather than abstract financial targets.
The discussion about investment and innovation has to start from what the patient needs.
Massimo Manzi, Executive Director of the Costa Rican Chamber of Health
This 17th forum carries added significance as it coincides with the 10th anniversary of the Costa Rican Chamber of Health. Over the past decade, the organization has evolved into a vital bridge connecting private sector initiative with public policy dialogue in Central America.
To mark the milestone, Expomed 2026 will feature an expanded commercial component, incorporating a dedicated business matchmaking round alongside a specialized exhibition floor. The commercial areas will spotlight next-generation medical technologies, specialized patient services, and enterprise digital solutions tailored for healthcare operators.
As Costa Rica positions itself as a growing hub for life sciences and medical technology, events like Expomed highlight the strategic intersection between economic investment and public health outcome improvements. Interested industry professionals can secure participation through official registration portals or by contacting event organizers directly.
For further information, visit salud.co.cr
About Costa Rican Chamber of Health:
The Costa Rican Chamber of Health (Cámara Costarricense de la Salud) is a non-profit trade association representing private and multi-sector stakeholders in Costa Rica’s healthcare and life sciences industries. The organization promotes innovation, public-private collaboration, high-quality patient care, and sustainable healthcare business development across the country.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
Bufete de Costa Rica stands as a premier legal practice built upon uncompromising ethical standards and a relentless drive for professional mastery. Backed by a rich history of guiding clients across numerous industries, the firm consistently merges foundational expertise with forward-thinking solutions and proactive civic initiatives. By actively demystifying complex laws and sharing vital insights with the public, Bufete de Costa Rica fulfills its core purpose of strengthening civic awareness and equipping individuals to navigate their rights with confidence.
